Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
Biogen Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One increased by 11.5% to $900.00M in Q1 2026 compared to the prior quarter. Over 3 years (FY 2020 to FY 2025), Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One shows a downward trend with a -14.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Higher values indicate greater near-term liquidity from the investment portfolio, reducing reliance on external financing.
Detailed definition
This represents the portion of the available-for-sale debt securities portfolio that is scheduled to mature within the f...
Peer comparison
Consistent with standard treasury management practices for large-cap firms with significant cash reserves.
other_available_for_sale_securities_debt_maturities_with_de2040Historical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.31B | $1.41B | $1.54B | $2.01B | $2.14B | $1.25B | $1.47B | $2.14B | $3.46B | $97.60M | $807.20M | $900.00M |
| QoQ Change | — | +8.0% | +9.0% | +30.2% | +6.5% | -41.7% | +18.3% | +45.4% | +61.5% | -97.2% | +727.0% | +11.5% |
| YoY Change | — | — | — | — | +63.2% | -11.9% | -4.4% | +6.8% | +62.0% | — | — | — |
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One at Other Companies
Frequently Asked Questions
- What is Biogen's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, year one?
- Biogen (BIIB) reported debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, year one of $900.00M in Q1 2026.
- What is the long-term trend for Biogen's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, year one?
- Over 3 years (2020 to 2025), Biogen's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, year one has grown at a -14.2% compound annual growth rate (CAGR), from $1.28B to $807.20M.
- What does debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, year one mean?
- The value of debt investments maturing within the next twelve months.